---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-074014"
form_type: "8-K"
ticker: "BCYC"
cik: "0001761612"
company_name: "BICYCLE THERAPEUTICS PLC"
filed_at: "2023-06-23T23:59:59+00:00"
generated_at: "2026-06-13T18:14:27.671078+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Bicycle Therapeutics appoints Alethia Young as CFO, replaces Lee Kalowski

## Summary
- Alethia Young appointed CFO effective ~July 17, 2023; Lee Kalowski resigned effective June 22, 2023.
- Young previously CFO of Graphite Bio (GRPH) and biotech analyst at Cantor, Credit Suisse, Deutsche Bank.
- Young receives base salary $480,000, bonus target 50%, signing bonus $100,000, option for 120,000 shares.
- Travis Thompson appointed Chief Accounting Officer effective June 22, 2023; joined company in 2018.
- No family relationships or related-party transactions between new officers and company.

## SEC filing metadata
- accession: 0001104659-23-074014
- form_type: 8-K
- ticker: BCYC
- cik: 0001761612
- company_name: BICYCLE THERAPEUTICS PLC
- filed_at: 2023-06-23T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1761612/000110465923074014/0001104659-23-074014-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1761612/000110465923074014/tm2319507d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-074014
- JSON: https://secwatch.observer/filing/0001104659-23-074014.json
- Plain text: https://secwatch.observer/filing/0001104659-23-074014.txt

## Key facts
- Executive change
  Travis Thompson was appointed as Chief Accounting Officer at BICYCLE THERAPEUTICS PLC.
  - Action: appointed
  - Role: Chief Accounting Officer
  source text: the Board appointed Travis Thompson as the Company’s Chief Accounting Officer and principal accounting officer, effective as of the Transition Date
  evidence_url: https://www.sec.gov/Archives/edgar/data/1761612/000110465923074014/0001104659-23-074014-index.htm
- Executive change
  Alethia Young was appointed as Chief Financial Officer at BICYCLE THERAPEUTICS PLC.
  - Action: appointed
  - Role: Chief Financial Officer
  source text: the Board of Directors (the “ Board ”) of Bicycle Therapeutics plc (the “ Company ”) appointed Alethia Young as Chief Financial Officer and principal financial officer, effective on or about July 17, 2023
  evidence_url: https://www.sec.gov/Archives/edgar/data/1761612/000110465923074014/0001104659-23-074014-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.